Luc-André Granier M.D., Ph.D.
CEO, Medical Director and Co-Founder of Advicenne
* International League Against Epilepsy, **American Society of Nephrology, *** International Pediatric Nephrology Society
Director of Operations, General Manager and Co-Founder of Advicenne
Caroline co-founded Advicenne in 2007 and is the Company’s General Manager. She is responsible for the pharmaceutical development and project management of Advicenne’s pipeline. Caroline has extensive experience in research project management and in sub-contracting early stage clinical projects.
Prior to Advicenne Caroline co-founded Synt:em in 1995, a French biotech
company focused on the treatment of oncology, pain management, and diseases of the central nervous system and held the position of Chief Operating Officer. Synt:em was acquired by CLL Pharma S.A in 2005.
Caroline has an engineering degree in Industrial Biology from The UTC (France) and is a management school graduate (IEDE Montpellier).
Chief Business Officer
He has more than 25 years experience in international R&D, business development and marketing & sales in the pharmaceutical industry. During his career, Ludovic launched more than 15 new original products for rare diseases or for highly specialized medicines.
Prior to Advicenne, Ludovic was 12 years at Shire where he served as Marketing Manager,
Business Unit Director, Marketing Director and Commercial Operations Head of France and BeNeLux,
Before that he held various managerial and leadership roles in sales, marketing and business development at L’Oréal, Servier and Laboratoires Expanscience. where he originated, signed and executed 13 partnerships (registration, commercial) in more than 20 countries.
Ludovic has a Doctorate in Pharmacy (PharmD) and a Master in Industrial Pharmacy from Lyon I University and an MBA from HEC Paris (and Mc Gill – Montreal).
Chief Financial Officer
Graduated from Montpelier Business School, Paul Michalet is a member of the SFAF (France Society of Financial Analysts) and IFA ( French Institute of Board Directors).
Paul has held a number of senior executive positions in the last 30 years. He had various responsibilities in finance for 10 years in manufacturing and service industries and, in the past 20 years, he held senior executive positions in biotechnology companies active in the chemical, cosmetics and Pharma industries.
He most recently was CEO of iDD biotech, a biotech company specialized in monoclonal antibodies drug development
in the cancer field and was previously CFO and CBO in charge of the strategy, financing and the business development of Fermentalg, an industrial biotech company listed in Compartment C of Eurolist Paris for which he negotiated the Joint Venture with Sofiprotéol.
During his various senior positions, Paul negotiated several important license agreements and he achieved cumulative fund raising of over EUR200m under various formats, including 3 successful IPOs: Fermentalg in 2014, MetaboliceExplorer in 2007 and Coletica in 2000 (today BASF Beauty Care Solutions) for which he also prepared the trade sale.
Catherine Guittet, Pharmacien
Head of Clinical Operations Department
Nathalie Lemarié, Pharmacien
Director of Regulatory Affairs & Qualified Person
Nathalie obtained her Ph.D. in Pharmacy and Masters in Company Administration at the University of Montpellier, France.
Financial & Logistics Director
Sarah is a graduate in Applied Economics from the University of Antwerp in Belgium.
Julie Rachline, PhD.
Julie holds a Ph.D. in Neuropharmacology from Ecole Normale Supérieure and a MS from ESCP-Europe.